| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df493aec811c46b53ab16f0e1a115b8a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-67 |
| filingDate |
2017-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad0f41e25363971ab6b9e11c1280da98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c9d5bfb8cbbeef202dd97c7085be0eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b46b3e8ec08dce8c9ea49ba96d1f5808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fbf3d8fe317bf33888132798bbcae04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71296298fd84081ecd84e962b635940
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba815b94577535a5798f9f789ea66232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f5b5982593a639d44860c495542a959
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab6313a1cd74b6eeb8f5062e4bf1e3b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bc877f98d25eefe0a5d57c9ab17f1b8 |
| publicationDate |
2021-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3458590-B9 |
| titleOfInvention |
Polynucleotides encoding -galactosidase a for the treatment of fabry disease |
| priorityDate |
2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |